What is ImmunityBio, Inc.'s insurance premium financing asset?

ImmunityBio, Inc. (IBRX) reported insurance premium financing asset of $884K in Q1 2026.

How has ImmunityBio, Inc.'s insurance premium financing asset changed year-over-year?

ImmunityBio, Inc.'s insurance premium financing asset increased by 180.6% year-over-year, from $315K to $884K.

What is the long-term trend for ImmunityBio, Inc.'s insurance premium financing asset?

Over 5 years (2020 to 2025), ImmunityBio, Inc.'s insurance premium financing asset has grown at a 4.3% compound annual growth rate (CAGR), from $1.42M to $1.75M.

ImmunityBio, Inc. IBRX Insurance premium financing asset

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept ibrx:InsurancePremiumFinancingAsset.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s insurance premium financing asset.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s insurance premium financing asset?: ImmunityBio, Inc. (IBRX) reported insurance premium financing asset of $884K in Q1 2026.
How has ImmunityBio, Inc.'s insurance premium financing asset changed year-over-year?: ImmunityBio, Inc.'s insurance premium financing asset increased by 180.6% year-over-year, from $315K to $884K.
What is the long-term trend for ImmunityBio, Inc.'s insurance premium financing asset?: Over 5 years (2020 to 2025), ImmunityBio, Inc.'s insurance premium financing asset has grown at a 4.3% compound annual growth rate (CAGR), from $1.42M to $1.75M.